problem is the board never acts for minority shareholders, shafts them with no qualms if it suits their own purposes
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025